A GROWING NUMBER of African-Americans--especially women--are being diagnosed with the gastrointestinal disorder known as irritable bowel syndrome (IBS).
Doctors say about 15 percent of African-American women who complain of abdominal pain have been diagnosed with the disease, which is characterized by severe cramping and diarrhea, or bloating and constipation. Overall IBS affects up to 20 percent of the population, according to the International Foundation for Functional Gastrointestina ...
Author: American Family Physician
CLICK HERE TO READ THE REST OF THIS ARTICLE
08/27/2008
No Link Found Between Diverticular Disease And Consumption Of Nuts, Seeds, And Corn
A new study published in the August 27 issue of JAMA reports good news for men who enjoy nuts, corn, or popcorn. Researchers studying a large cohort of men have found that consumption of these foods does not increase the risk of diverticulosis or diverticular complications - a conclusion that is contrary to common beliefs. Diverticular disease is characterized by having diverticula in the colon, and it often leads to diverticulitis and diverticular bleeding.
more IBS info
|
08/01/2008
Experts Continue To Cite Bifantis As Promising Probiotic Treatment For Irritable Bowel Syndrome
Two new review articles that cover therapeutic approaches to irritable bowel syndrome (IBS) in the July issue of Nutrition in Clinical Practice, cite growing evidence that probiotics, and specifically Bifidobacterium infantis 35624 (Bifantis®), are effective in helping manage IBS. Both articles point to data that suggest Bifantis (available in the U.S.
more IBS info
|
07/23/2008
Clinical Trial For The Treatment Of Inflammatory Bowel Disease Begins At Tel Aviv Sourasky Medical Center
Anadis Ltd (ASX:ANX; OTC:ANDIY), a biopharmaceutical company focused on research, development and production of immune milk (colostrum)-derived polyclonal antibodies and other proteins to address major diseases, today announces the initiation of a clinical trial with top clinical scientists at Tel Aviv Sourasky Medical Center in Israel.
more IBS info
|
07/16/2008
Drug For Treatment Of Inflammatory Bowel Disease - New Formula Allows For Greater Absorption, Fewer Doses
Physician-scientists from NewYork-Presbyterian/Weill Cornell, involved in clinical trials for a new drug for those who suffer from inflammatory bowel disease (IBD), say it is the best option among available drugs. Gaizo is a reformulation of the active ingredient 5-ASA in currently available drugs. However, the researchers found that 99 percent of the active ingredient in the new pill is released in the colon compared to only 70 percent in other common IBD drugs. Dr.
more IBS info
|
07/16/2008
Stem Cells Heal Chronic Inflammation In The Gut - May Help Restore Immune System To Normal Function For Crohn's Disease
Stem cells are being studied at NewYork-Presbyterian/Weill Cornell to heal the gut in subjects suffering from Crohn's disease. Physician-scientists believe that these cells might help to restore the ability of the immune system to control inflammation by secreting anti-inflammatory proteins into the digestive tract, allowing for regeneration of tissue and prevention of scar tissue.
more IBS info
|
